Press MF - Search Results

1

Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer.

Ring A, Campo D, Porras TB, Kaur P, Forte VA, Tripathy D, Lu J, Kang I, Press MF, Jeong YJ, Snow A, Zhu Y, Zada G, Wagle N, Lang JE. Ring A, et al. Among authors: press mf. Ann Surg Oncol. 2022 May;29(5):2882-2894. doi: 10.1245/s10434-021-11135-2. Epub 2022 Jan 9. Ann Surg Oncol. 2022. PMID: 35000083 Free PMC article.

2

Reduction of BRCA1 expression in sporadic ovarian cancer.

Zheng W, Luo F, Lu JJ, Baltayan A, Press MF, Zhang ZF, Pike MC. Zheng W, et al. Among authors: press mf. Gynecol Oncol. 2000 Mar;76(3):294-300. doi: 10.1006/gyno.1999.5664. Gynecol Oncol. 2000. PMID: 10684699

3

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer.

Vogel CL, Cobleigh MA, Tripathy D, Gutheil JC, Harris LN, Fehrenbacher L, Slamon DJ, Murphy M, Novotny WF, Burchmore M, Shak S, Stewart SJ, Press M. Vogel CL, et al. J Clin Oncol. 2002 Feb 1;20(3):719-26. doi: 10.1200/JCO.2002.20.3.719. J Clin Oncol. 2002. PMID: 11821453 Corrected and republished. Clinical Trial.

4

P7 antigen expression in human breast cancer.

Yang X, Groshen S, Formenti SC, Davidson NE, Press MF. Yang X, et al. Among authors: press mf. Clin Cancer Res. 2003 Jan;9(1):201-6. Clin Cancer Res. 2003. PMID: 12538470

5

Prognostic and predictive value of HER2 extracellular domain in metastatic breast cancer treated with lapatinib and paclitaxel in a randomized phase III study.

Finn RS, Gagnon R, Di Leo A, Press MF, Arbushites M, Koehler M. Finn RS, et al. Among authors: press mf. J Clin Oncol. 2009 Nov 20;27(33):5552-8. doi: 10.1200/JCO.2008.21.1763. Epub 2009 Oct 26. J Clin Oncol. 2009. PMID: 19858400 Clinical Trial.

6

Molecular markers for breast cancer diagnosis, prognosis and targeted therapy.

Lang JE, Wecsler JS, Press MF, Tripathy D. Lang JE, et al. Among authors: press mf. J Surg Oncol. 2015 Jan;111(1):81-90. doi: 10.1002/jso.23732. Epub 2014 Aug 5. J Surg Oncol. 2015. PMID: 25091830 Review.

7

Prognostic Value of Intrinsic Subtypes in Hormone Receptor-Positive Metastatic Breast Cancer Treated With Letrozole With or Without Lapatinib.

Prat A, Cheang MC, Galván P, Nuciforo P, Paré L, Adamo B, Muñoz M, Viladot M, Press MF, Gagnon R, Ellis C, Johnston S. Prat A, et al. Among authors: press mf. JAMA Oncol. 2016 Oct 1;2(10):1287-1294. doi: 10.1001/jamaoncol.2016.0922. JAMA Oncol. 2016. PMID: 27281556

8

RNA-Seq of Circulating Tumor Cells in Stage II-III Breast Cancer.

Lang JE, Ring A, Porras T, Kaur P, Forte VA, Mineyev N, Tripathy D, Press MF, Campo D. Lang JE, et al. Among authors: press mf. Ann Surg Oncol. 2018 Aug;25(8):2261-2270. doi: 10.1245/s10434-018-6540-4. Epub 2018 Jun 4. Ann Surg Oncol. 2018. PMID: 29868978 Free PMC article.

9

CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer.

Ring A, Nguyen C, Smbatyan G, Tripathy D, Yu M, Press M, Kahn M, Lang JE. Ring A, et al. Cancers (Basel). 2018 Dec 19;10(12):525. doi: 10.3390/cancers10120525. Cancers (Basel). 2018. PMID: 30572639 Free PMC article.

10

Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy.

Caswell-Jin JL, McNamara K, Reiter JG, Sun R, Hu Z, Ma Z, Ding J, Suarez CJ, Tilk S, Raghavendra A, Forte V, Chin SF, Bardwell H, Provenzano E, Caldas C, Lang J, West R, Tripathy D, Press MF, Curtis C. Caswell-Jin JL, et al. Among authors: press mf. Nat Commun. 2019 Feb 8;10(1):657. doi: 10.1038/s41467-019-08593-4. Nat Commun. 2019. PMID: 30737380 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

256 results

Search Page